发明名称 Histone demethylase inhibitors
摘要 The present invention relates generally to compositions and methods for treating cancer and neoplastic diseases. Provided herein are substituted imidazole-pyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase enzymes. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
申请公布号 US9527829(B2) 申请公布日期 2016.12.27
申请号 US201414774338 申请日期 2014.03.13
申请人 Celgene Quanticel Research, Inc. 发明人 Kanouni Toufike;Nie Zhe;Stafford Jeffrey Alan;Veal James Marvin
分类号 C07D401/00;C07D401/04;C07D401/14;A61K31/4439;A61K31/444;A61K31/4545;A61K31/4709;A61K31/5377;C07D405/14;C07D413/14;A61K31/00 主分类号 C07D401/00
代理机构 Wiley Rein LLP 代理人 Wiley Rein LLP
主权项 1. A compound having the structure of Formula (II): or a pharmaceutically acceptable salt thereof, wherein: R1 is hydrogen, halogen, —OH, —OR5, —N(R5)2, alkyl, carbocyclyl, heterocyclyl, aryl, heteroaryl, carbocyclylalkyl, heterocyclylalkyl, aralkyl, or heteroarylalkyl; R2 is alkyl, carbocyclyl, heterocyclyl, aryl, heteroaryl, carbocyclylalkyl, heterocyclylalkyl, aralkyl, or heteroarylalkyl; R3 is hydrogen; R4 is tetrazolyl; and each R5 is independently hydrogen, alkyl, carbocyclyl, heterocyclyl, aryl, heteroaryl, carbocyclylalkyl, heterocyclylalkyl, aralkyl, or heteroarylalkyl.
地址 San Diego CA US